Evidence map›Paper›PMID 26927798›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2016

Cutting Edge: CLEC5A Mediates Macrophage Function and Chronic Obstructive Pulmonary Disease Pathologies.

Brian W Wortham, Bryan L Eppert, Jennifer L Flury, Sara Morgado Garcia, Walter R Donica, Andrew Osterburg, Barbara Joyce-Shaikh, Daniel J Cua, Michael T Borchers

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Alveolar Macrophage Heterogeneity Goes up in Smoke?American journal of respiratory cell and molecular biology · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Vitamin DEBioMedicine · 2019
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Brian W WorthamDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267; and.
Bryan L EppertDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267; and.
Jennifer L FluryDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267; and.
Sara Morgado GarciaDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267; and.
Walter R DonicaDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267; and.
Andrew OsterburgDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267; and.ORCID http://orcid.org/0000-0003-3018-9134
Barbara Joyce-ShaikhMerck Research Laboratories, Palo Alto, CA 94304.
Daniel J CuaMerck Research Laboratories, Palo Alto, CA 94304.
Michael T BorchersDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267; and michael.borchers@uc.edu.
University of Cincinnati Medical Center · USMerck & Co., Inc., Rahway, NJ, USA (United States) · US

Funding

Gene-Environment Interactinos Training ProgramT32ES016646 · NIEHS · UNIVERSITY OF CINCINNATI · PI PUGA, ALVARO · 2008 to 2014
$2.1M
Clec5a regulation of Macrophage function in COPDR01HL119538 · NHLBI · UNIVERSITY OF CINCINNATI · PI BORCHERS, MICHAEL · 2014 to 2017
$1.6M
Novel Reagents in Mouse Models of Autoimmune COPDR21HL109635 · NHLBI · UNIVERSITY OF CINCINNATI · PI BORCHERS, MICHAEL · 2011 to 2012
$432k
Natural Killer Cell Functions in COPDI01BX002347 · VA · CINCINNATI VA MEDICAL CENTER RESEARCH · PI BORCHERS, MICHAEL · 2015 to 2018
–
BLRD VA I01 BX002347NHLBI NIH HHS R01 HL119538NHLBI NIH HHS R21 HL109635NIEHS NIH HHS T32 ES016646
6 · The paper itself

Abstract

Chronic obstructive pulmonary disease (COPD) is a devastating disease with no effective therapies. We investigated the role of the C-type lectin receptor, CLEC5A, in macrophage activation and pulmonary pathogenesis in a mouse model of COPD. We demonstrate that CLEC5A is expressed on alveolar macrophages in mice exposed long-term to cigarette smoke (CS), as well as in human smokers. We also show that CLEC5A-mediated activation of macrophages enhanced cytokine elaboration alone, as well as in combination with LPS or GM-CSF in CS-exposed mice. Furthermore, usingClec5a-deficient mice, we demonstrate that CS-induced macrophage responsiveness is mediated by CLEC5A, and CLEC5A is required for the development of inflammation, proinflammatory cytokine expression, and airspace enlargement. These findings suggest a novel mechanism that promotes airway inflammation and pathologies in response to CS exposure and identifies CLEC5A as a novel target for the therapeutic control of COPD pathogenesis.

Indexed as

AnimalsBronchoalveolar Lavage FluidCells, CulturedCytokinesDisease Models, AnimalGranulocyte-Macrophage Colony-Stimulating FactorInflammationLectins, C-TypeLipopolysaccharidesLungMacrophage ActivationMacrophages, AlveolarMiceMice, Inbred C57BLMice, KnockoutPulmonary Disease, Chronic ObstructiveClec5a protein, mouseCytokinesGranulocyte-Macrophage Colony-Stimulating FactorLectins, C-TypeLipopolysaccharidesReceptors, Cell SurfaceTobacco Smoke Pollution

Identifiers

PMID26927798
PMCPMC4821706
OpenAlexW2335946155

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.